Tenax Therapeutics (TENX) Tops Q3 EPS by 6c

Tenax Therapeutics (NASDAQ: TENX) reported Q3 EPS of ($0.10), $0.06 better than the analyst estimate of ($0.16).

For earnings history and earnings-related data on Tenax Therapeutics (TENX) click here.

You May Also Be Interested In

• Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion
• Activist Jana Partners calls for Six Flags sale - WSJ
• AppLovin drops 3% as Edgewater analyst warns of stalled market share growth